• Users Online: 1230
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Leishmania vaccines entered in clinical trials: A review of literature

Moafi Mohammad, Rezvan Hossein, Sherkat Roya, Taleban Roya

Year : 2019| Volume: 10| Issue : 1 | Page no: 95-95

   This article has been cited by
1 Role of Host and Parasite MIF Cytokines during Leishmania Infection
Thomas Holowka,Richard Bucala
Tropical Medicine and Infectious Disease. 2020; 5(1): 46
[Pubmed]  [Google Scholar] [DOI]
2 The Delay in the Licensing of Protozoal Vaccines: A Comparative History
Clarisa Beatriz Palatnik-de-Sousa,Dirlei Nico
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
3 Synthesis of N-substituted indole derivatives as potential antimicrobial and antileishmanial agents
Shweta Tiwari,Seema Kirar,Uttam Chand Banerjee,Neerupudi Kumar Balu,Sushma Singh,Aabid Abdullah Wani,Prasad V. Bharatam,Inder Pal Singh
Bioorganic Chemistry. 2020; : 103787
[Pubmed]  [Google Scholar] [DOI]
4 Development of nano-carriers for Leishmania vaccine delivery
Anis Askarizadeh,Ali Badiee,Ali Khamesipour
Expert Opinion on Drug Delivery. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges
Kiran Saleem,Zainab Khursheed,Christophe Hano,Iram Anjum,Sumaira Anjum
Nanomaterials. 2019; 9(12): 1749
[Pubmed]  [Google Scholar] [DOI]
6 Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis
Camila dos Santos Meira,Lashitew Gedamu
Microorganisms. 2019; 7(12): 695
[Pubmed]  [Google Scholar] [DOI]


Read this article